These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10611726)

  • 21. Treatment advances for CMV retinitis.
    Rahhal FM
    AIDS Read; 1999; 9(1):28, 31-4. PubMed ID: 12728880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
    Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
    Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of CMV retinitis in Africa.
    Kestelyn P
    Ocul Immunol Inflamm; 1999 Dec; 7(3-4):173-7. PubMed ID: 10611725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
    Polis MA; deSmet MD; Baird BF; Mellow S; Falloon J; Davey RT; Kovacs JA; Palestine AG; Nussenblatt RB; Masur H
    Am J Med; 1993 Feb; 94(2):175-80. PubMed ID: 8381583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus retinitis and acquired immunodeficiency syndrome.
    Jabs DA; Enger C; Bartlett JG
    Arch Ophthalmol; 1989 Jan; 107(1):75-80. PubMed ID: 2535932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
    Moyle G; Harman C; Mitchell S; Mathalone B; Gazzard BG
    J Infect; 1992 Jul; 25(1):21-7. PubMed ID: 1326012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus and the acquired immunodeficiency syndrome.
    Tyms AS; Taylor DL; Parkin JM
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():89-105. PubMed ID: 2541127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus retinitis and response to therapy with ganciclovir.
    Henderly DE; Freeman WR; Causey DM; Rao NA
    Ophthalmology; 1987 Apr; 94(4):425-34. PubMed ID: 3035453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of cytomegalovirus retinitis in patients with AIDS.
    Mills J; Jacobson MA; O'Donnell JJ; Cederberg D; Holland GN
    Rev Infect Dis; 1988; 10 Suppl 3():S522-31. PubMed ID: 2847289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
    Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus retinitis in AIDS.
    Wilson RJ
    J Am Optom Assoc; 1992 Jan; 63(1):49-58. PubMed ID: 1316393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome.
    Gross JG; Bozzette SA; Mathews WC; Spector SA; Abramson IS; McCutchan JA; Mendez T; Munguia D; Freeman WR
    Ophthalmology; 1990 May; 97(5):681-6. PubMed ID: 2160634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Keijer WJ; Burger DM; Neuteboom GH; Vrooland JL; Meenhorst PL; Koks CH; Beijnen JH
    Pharm World Sci; 1993 Apr; 15(2):56-67. PubMed ID: 8387852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foscarnet sodium.
    Minor JR; Baltz JK
    DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uveitis in patients treated with intravenous cidofovir.
    Cochereau I; Doan S; Diraison MC; Mousalatti H; Guvenisik N; Ren L; Hoang-Xuan T
    Ocul Immunol Inflamm; 1999 Dec; 7(3-4):223-9. PubMed ID: 10611731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Au Eong KG; Beatty S; Charles SJ
    Postgrad Med J; 1999 Oct; 75(888):585-90. PubMed ID: 10621898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.